New Korean Drug for use in Hepa B Disease

Korean Food and Drug Administration is proud to announce the development of a new Hepa B drug Levovir Capsule; the new drug that will be made available in the market for patients treating hepa B infections.

The drug, developed by Bukwang Pharmaceuticals, Co., was a product of an intensive 10 years of clinical research and drug development which costs about $96 million since day 1.

Levovir Capsule is the first local drug that was approved for the treatment of the above disease. Clevudine, Levovir's main ingredient developed in the United States, is legally sold and developed by Bukwang Pharmaceuticals, Co. Please go to The Korean Herald for more information.

---

More Blog Topics at:

http://hivaidsresourcecenter.blogspot.com/
http://healthlines.blogspot.com/

Green Tea improves patients' conditions with Liver Fibrosis

Reading on HIVandHEpatitis.com website, it shows that patients drinking green tea have shown positive response to slow down the development of liver fibrosis among patients with Hepatitis, especially Hepatitis C.

The American Association for the Study of Liver Diseases' (AASLD) annual meeting on October this year has shown preclinical trial studies and observations which shows how green tea components (polyphenols) can act as anti-fibrotic agent for patients with chronic hepatitis C infection.

The anti-inflammatory and anti-oxidant properties of green tea polyphenols provides a substantial clues that it will soon be explored to extract substances that will help patients with hepatitis infections to avoid liver damage and collapse. More information at HIVandHEpatitis.com.

Adefovir Dipivoxil and Telbivudine effective for HBV Treatment

The 57th Annual Meeting of the American Society for Liver Diseases (AASLD) found Adefovir Dipivoxil to be more effective in controlling virus reproduction for chronic Hepatitis B patients. Moreover, during the 3 years of research, patient's showed biological tolerance on daily consumption of 10 mg the said drug, showing no other signs of secondary disease resulting to the adverse effects of Adefovir Dipivoxil.

Similarly, Telbivudine, another antiviral drug used for Hepatitis B, was helpful if a patient is switched to Telbivudine viral treatment after 24 weeks of initial Lamivudine use. More readings on docguide.com. (1) (2)

Hepatitis B Viruses Replicating